New research shows bariatric surgery's powerful impact on liver health, reducing fatty liver disease risk and improving ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Fatty acid synthase (FASN), an enzyme that drives de novo lipogenesis, plays a relevant role in metabolic disorders such as obesity, non-alcoholic fatty liver disease (NAFLD) or type 2 diabetes.

The most well-known cause of fatty liver is drinking too much alcohol. This condition, called alcoholic fatty liver disease, ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

Pikeville Medical Center has announced the addition of Dr. Samir Softic, a board-certified pediatric gastroenterologist, to ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

As the new year begins, people in Columbia are embracing the "sober curious" movement, opting for mocktails and alcohol-free ...